how to relieve nausea from semaglutide Top 5 Common Side Effects and Minimize Them What Foods Make You Sick

Beverly Hills medical weight loss clinic offering GLP-1 therapy, semaglutide, weight loss injections, and physician-supervised programs

Learn why GLP-1 drugs cannot rebuild metabolism, and how SCFAs & gut bacteria may support lasting balance

G49, a dual glucagon/glucagon-like peptide-1 receptor agonist, triggers an inter-organ crosstalk between adipose tissue, pancreas and liver, leading to brown fat activation with the final outcomes of increased energy expenditure and body weight loss.

Used together in a compounded formulation, this pairing can elevate results for patients on a wellness or weight loss journey

Combining the therapeutic approaches of GLP-1 agonists (which target extrahepatic mechanisms for metabolic disorders) with resmetirom (which target intrahepatic mechanisms for MASH and liver fibrosis) seems like a promising strategy for addressing fat accumulation, inflammation, and fibrosis associated with MASH.